IRIS
VILLANI, ROSANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.591
NA - Nord America 1.621
AS - Asia 578
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 3
OC - Oceania 1
Totale 4.808
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.617
IE - Irlanda 915
IT - Italia 472
SE - Svezia 451
UA - Ucraina 357
CN - Cina 341
SG - Singapore 162
FR - Francia 97
DE - Germania 93
FI - Finlandia 71
GB - Regno Unito 47
TR - Turchia 25
IN - India 23
PL - Polonia 19
AT - Austria 18
BE - Belgio 15
CZ - Repubblica Ceca 13
JP - Giappone 8
RU - Federazione Russa 6
NL - Olanda 5
EG - Egitto 4
EU - Europa 4
IR - Iran 4
RO - Romania 4
CA - Canada 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BR - Brasile 2
CH - Svizzera 2
ES - Italia 2
ET - Etiopia 2
HK - Hong Kong 2
HU - Ungheria 2
KR - Corea 2
PH - Filippine 2
PK - Pakistan 2
TW - Taiwan 2
ZA - Sudafrica 2
AU - Australia 1
CL - Cile 1
LK - Sri Lanka 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
MY - Malesia 1
SA - Arabia Saudita 1
SM - San Marino 1
VN - Vietnam 1
Totale 4.808
Salva come PNG Salva come JPEG
Città #
Dublin 913
Nyköping 313
Chandler 254
Jacksonville 217
Singapore 118
Wilmington 113
Dearborn 103
Princeton 89
New York 60
Nanjing 57
Beijing 55
Helsinki 54
Ashburn 52
Ann Arbor 51
Foggia 50
Rome 33
Nanchang 23
Des Moines 22
Munich 22
Bari 21
Shenyang 19
Kraków 18
San Mateo 18
Milan 17
Vienna 17
Kunming 16
Brussels 15
Hebei 14
Gravina In Puglia 13
San Severo 13
Stevenage 13
Boardman 11
Caserta 11
Hangzhou 11
Norwalk 11
Tianjin 11
Woodbridge 11
Jiaxing 10
Brno 9
Houston 9
Orange 9
Seattle 9
Zhengzhou 9
Cagliari 8
Guangzhou 8
Los Angeles 8
Shanghai 8
Ariano Irpino 7
Changsha 7
Falls Church 7
Venice 7
London 6
Nembro 6
Borås 5
Como 5
Jinan 5
Manfredonia 5
Martina Franca 5
Redwood City 5
San Giovanni Rotondo 5
Stockholm 5
Wuhan 5
Bologna 4
Brindisi 4
Castellana Grotte 4
Ningbo 4
Parma 4
Saint-Fons 4
Terracina 4
Tokyo 4
Turin 4
Avigliano 3
Barletta 3
Buffalo 3
Candiolo 3
Changchun 3
Dagenham 3
Dallas 3
Fremont 3
Hilden 3
Naples 3
Niedernberg 3
Olomouc 3
Pimonte 3
Saga 3
Saint Paul 3
San Jose 3
Taizhou 3
Toronto 3
Washington 3
Acquaviva Delle Fonti 2
Addis Ababa 2
Atlanta 2
Bellville 2
Bitonto 2
Carpi 2
Cedar Knolls 2
Central 2
Cutrofiano 2
Fuzhou 2
Totale 3.144
Salva come PNG Salva come JPEG
Nome #
Direct-acting antivirals (daas) increase the serum vegf level in patients with chronic hepatitis c: a rationale for tumor recurrence 227
Strategie per la gestione del paziente HBV+ in terapia con immunosoppressori 169
Ulcere da decubito, prevenzione e trattamento. 145
Liver toxicity induced by amiodarone is dependent on mitochondria Complex I impairment, OXPHOS uncoupling and cardiolipin peroxidation. 139
DAAs rapidly reduce inflammation but increase serum VEGF level: A rationale for tumor risk during anti-HCV treatment 104
Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet 101
To be or not to be: A two years surveillance for a CA 19-9 persistent elevation before cancer diagnosis and bone metastases 98
DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment 96
Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease 95
Analogs in the treatment of chronic hepatitis B: real life experience with tenofovir and entecavir 83
Effects of dietary fatty acids and cholesterol excess on liver injury: a lipidomic approach 83
Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta-analysis of randomized trials 83
Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications 78
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients with Circulating Cryoglobulins 77
Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis 77
Amiodarone induces liver toxicity by impairing liver mitochondria bioenergetics and redox balance. 76
Treatment of chronic HCV infection in the era of protease inhibitors 75
Biopsychosocial predictors of interferon-related depression in patients with Hepatitis C 73
HOW OFTEN HAVE WE SAID: IF I HAD THOUGHT OF IT BEFORE? 72
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 72
Efficacy and safety of direct-acting antivirals in elderly with chronic hepatitis C: results from a retrospective cohort study 72
Lipid metabolism in development and progression of hepatocellular carcinoma 71
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry 68
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 67
Two-year outcomes of patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 65
Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal 65
Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry 63
NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients 62
Direct-acting antivirals restore systemic redox homeostasis in chronic HCV patients (Q1 WoS) 60
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: Insights from the GARFIELD-AF registry 59
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists 59
Molecular Aspects and Treatment of Iron Deficiency in the Elderly 59
Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid analogues 58
Oxysterols and redox signaling in the pathogenesis of non alcoholic fatty liver disease. 57
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation 57
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases 56
Direct-acting antivirals improve kidney function in diabetic patients with HCV infection and chronic kidney disease 55
Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation (Q1 WoS) 53
Diagnostic reliability of the procalcitonin serum marker in septic frail patient 51
Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry 50
Pharmacological treatment of depression in Alzheimer's disease: A challenging task 50
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation 50
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 48
Liver fat content assessed by conventional B-mode ultrasound and metabolic profile in non-diabetic patients: Implications for clinical practice 47
Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry 47
Direct-acting antivirals improve kidney function in diabetic patients with HCV infection and chronic kidney disease 47
Age, mitochondria and bladder cancer 46
In-hospital mortality and length of stay in cirrhotic patients with sepsis treated with non-selective beta-blockers 46
Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression 46
Asymptomatic saccular portal vein aneurysm: a case report and review of the literature 46
High prevalence of false positive SARS-CoV2 serology in a cohort of patients with liver autoimmune diseases 43
Direct-acting antivirals for HCV treatment in older patients: A systematic review and meta-analysis 43
Unmet clinical questions in elderly patients with locally advanced and metastatic bladder cancer 43
Molecular Aspects and Treatment of Iron Deficiency in the Elderly 43
A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model 42
Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression (Q1 WoS) 37
Management of intermediate-stage hepatocellular carcinoma in the elderly with transcatheter arterial chemoembolization failure: Retreatment or switching to systemic therapy? 37
Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experience 36
Temporal profile of SARS-CoV-2 viral load in posterior nasopharyngeal samples: Analysis of 944 patients in Apulia, Italy 36
Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy 36
Risk of Statin-Induced Hypertransaminasemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 35
US-GUIDED PROBE POSITIONING DOES NOT IMPROVE APPLICABILITY BUT REDUCES VARIABILITY IN LIVER STIFFNESS (FIBROSCAN) MEASUREMENT 34
THU-323-Impact of genetic polymorphisms associated with NAFLD on hepatic and vascular complications in diabetes 34
Impact of gender on event rates at 1-year in patients with newly diagnosed non-valvular atrial fibrillation: Contemporary perspective from the GARFIELD-AF registry 33
INSULINEMIC RESPONSE CURVE AFTER ORAL GLUCOSE TOLERANCE TEST IDENTIFIES EARLY ALTERATIONS OF GLUCOSE METABOLISM IN PATIENTS AFFECTED BY CHRONIC LIVER DISEASE 33
Management and 1-year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: Results from the prospective garfield-af registry 33
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 33
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry 33
Two-Dimensional Shear Wave Elastography Versus Transient Elastography: A Non-Invasive Comparison for the Assessment of Liver Fibrosis in Patients With Chronic Hepatitis C 32
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes 32
The glucose metabolic pathway as a potential target for therapeutics: Crucial role of glycosylation in alzheimer’s disease 32
Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry 31
Impact of genetic polymorphisms associated with NAFLD on hepatic and vascular complications in diabetes 31
Impatto della terapia con Peg-interferone o entecavir sulla fibrosi epatica mediante elastomeri: osservazione dopo 4 anni 31
Prevalence and risk factors for hospital-acquired anemia in internal medicine patients: learning from the "less is more" perspective 30
Improved risk stratification of patients with atrial fibrillation: An integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation 30
The dual role of glutamatergic neurotransmission in Alzheimer’s disease: From pathophysiology to pharmacotherapy 30
NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients 30
Management of intermediate-stage hepatocellular carcinoma in the elderly with transcatheter arterial chemoembolization failure: Retreatment or switching to systemic therapy? 30
Serum lipid profile in HCV patients treated with direct-acting antivirals: a systematic review and meta-analysis 30
Assessing the impact of COVID-19 on liver cancer management (CERO-19) 30
The GLP-1 receptor agonist Exendin-4 modulates hippocampal NMDA-receptor signalling in aged rats and improves cognitive impairment in diabetic elderly patients 28
The effect of direct-acting antivirals on hepatocellular carcinoma recurrence: still waiting for the turning point 28
Molecular mechanisms involved in HCC recurrence after direct-acting antiviral therapy 28
Liver fibrosis by FibroScan is highly prevalent in type 2 diabetic patients with NAFLD and fairly normal liver enzymes but increased uric acid 28
Lipid metabolism in development and progression of hepatocellular carcinoma 27
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives 27
Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes 25
Tocilizumab and liver injury in patients with COVID-19 25
Robot-assisted pelvic lymphadenectomy for prostate cancer. Potentially advantageous in the elderly? 24
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease 24
Krebs cycle derivatives, dimethyl fumarate and itaconate, control metabolic reprogramming in inflammatory human microglia cell line 23
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis 23
Pharmacological and toxicological effects of phytocannabinoids and recreational synthetic cannabinoids: Increasing risk of public health 21
Lenvatinib versus sorafenib as first-line therapy of advanced hepatocellular carcinoma: a systematic review and meta-analysis 19
Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease 17
null 17
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 17
Monocyte bioenergetics: An immunometabolic perspective in metabolic dysfunction-associated steatohepatitis 15
Exploring the Relationship between Epicardial Fat Thickness and Coronary Revascularization: Implications for Cardiovascular Health 13
Totale 5.195
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.947
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.947
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020383 0 0 0 0 68 75 71 16 44 9 45 55
2020/2021756 92 8 75 25 75 24 81 119 119 87 13 38
2021/2022553 28 11 17 10 44 35 38 39 88 93 28 122
2022/20231.996 209 86 91 51 86 161 28 154 1.022 19 50 39
2023/2024432 56 46 16 20 28 94 17 31 7 4 9 104
2024/2025316 121 14 53 62 66 0 0 0 0 0 0 0
Totale 5.242